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Introduction
Heterotopic Ossification (HO) is defined as the formation
of lamellar bone-like structures inside soft-tissues where bones
do not normally exist1-3. The condition was first noted in chil-
dren with fibrodysplasia ossificans progressiva (FOP) by Patin
in the 17th century4 and later described in more detail in World
War I veterans, paraplegic from intramedullary gunshot
wounds5. HO is usually acquired following trauma such as
major surgery, e.g. hip arthroplasty, burns, fractures, disloca-
tions, and soft-tissue damage6. It was not until 1968 that the
first three cases of HO were described in patients with brain
injuries7. In this study we focused on HO following neurolog-
ical injuries, neurogenic heterotopic ossification (NHO), which
usually affects major synovial joints that are surrounded by
spastic muscles2. NHO occurs most often in patients with trau-
matic brain injury (TBI) and traumatic spinal cord injury
(TSCI)8,9, but can also be associated with other causes of upper
motor neurone lesions such as stroke2. NHO typically develops
within two to four months from neurological insult and mani-
fests itself clinically as severe pain, swelling, erythema,
warmth and decreased range of movement10. Patients with
NHO usually develop lesions around larger joints, the hip
being the most common location, followed by the knees and
elbows11. A single joint is affected in ~40% of patients; in an-
other third, two joints are affected3. Following its initial clini-
cal manifestation, NHO tends to increase in size over the next
few months and is usually fully developed two years post neu-
rological injury12.
The prevalence of NHO in TSCI patients has been estimated
to be between 10% and 53%13. In TBI patients the prevalence
of NHO has been reported as being between 10% and
20%1,10,14. More recent estimates have reported the prevalence
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of NHO in TBI patients to be between 10% and 23% and 40-
50% in SCI populations15. All recent figures of NHO preva-
lence are notably higher than previous estimates of ~3% and
4% for TBI and TSCI patients, respectively, as described in
the early 60s and 80s of the last century16,17. It is of interest to
note that the prevalence of NHO after TSCI is lower in paedi-
atric patients than in adults, and spontaneous resorption of the
neurogenic HO has been reported in children18.
Many risk factors for NHO have been identified; most of
them, however, do not appear to have a clear biological basis,
evidenced by a weak association with the disease. These in-
clude vascular stasis, oedema, and prolonged swelling, as pos-
sibly contributing to NHO formation19,20. Demographic factors
such as age, gender and ethnicity have also been suggested to
increase the risk of NHO9. Some clinical characteristics and
factors associated with the clinical management of traumatic
neurological injuries such as length of time in coma, and arti-
ficial ventilation in patients with TBI6, as well as completeness
and level of spinal cord injuries in TSCI patients, have been
suggested to heighten the risk of NHO14,17. Marked spasticity,
length of time before being admitted to a specialised unit, as-
sociated fractures at the time of injury, pressure ulcers and uri-
Risk factors in development of NHO in traumatic spinal cord injuries
Risk Factors Goldman, 1980 Coelho & Beraldo, 2009 *Reznik et al, 2013
Gender M M M>F
Age 20-40 Not documented 31.4±10.9 years
Level of Injury Thoracic lesion Thoracic lesion Not significant
Complete/Incomplete **Complete **Complete ***AIS B
Spasticity Absent/Mild Absent/Mild Not significant
Pressure Ulcers Present Present Multiple pressure ulcers
DVT No No Significant
Length of Stay >6 weeks Not documented 207±175 days
Type of injury RTA Not documented RTA
Smoking Not documented No Not significant
Urinary complications Not documented Present Significant
M=Male; F= Female; AIS = ASIA Impairment Scale; RTA= Road Traffic Accident
*unpublished data
**As per Frankel Scale (Appendix 2)
*** see AIS Scale (Appendix 1)
Table 1. Risk factors for developing neurogenic heterotopic ossification.
Risk factors in development of NHO in traumatic head injuries
Risk factors Simonsen, 2007 Van Kampen, 2011 *Reznik et al, 2013
Gender M=F M>F M=100%
Age Median 23 years Median 35 years 39.6±15.5 years
Spasticity Severe Absent/mild Severe
Length of Stay Median 192 days Not documented 143±117 days
Immobilisation Yes Not significant Not documented
SAP levels Raised Not documented Not documented
Mechanical ventilation Not documented Mean 16.50 days Significant
Autonomic dysregulation Not documented Significant Not documented
Long bone fractures Not documented Not significant Significant
M=Male; F= Female; SAP= Serum Alkaline Phosphate 
*unpublished data
Table 2. Risk factors for developing neurogenic heterotopic ossification.
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nary tract infections have also been suggested as possible risk
factors in the development of NHO21. 
In order to identify patients with a high-level risk for NHO
after traumatic brain and spinal cord injuries, an audit was con-
ducted of patients admitted to specialised units at the Hamp-
stead Rehabilitation Centre in Adelaide, Australia. 
Materials and methods
Ethics approval was granted by the Royal Adelaide Hospital
Human Research Ethics Committee (RAH PROTOCOL NO:
121124).
Identification of patients
TBI and TSCI patients were identified using the Open Ar-
chitecture Clinical Information System used at the Hampstead
Rehabilitation Centre (OACIS). This OACIS system enables
data to be gathered from different clinical systems and up-
loaded into a central repository. The separation summaries and
clinical reports of all patients admitted to the Spinal Injury Unit
and Brain Injury Unit at the Hampstead Rehabilitation Centre
in Adelaide, Australia, between January 2007 and December
2012, were identified.
The diagnosis of NHO in TBI and TSCI patients was made
only when NHO became a clinically significant condition. The
screening protocol for TBI and TSCI patients admitted to the
specialised units at HRC included physiotherapy assessments
and medical imaging. 
Physiotherapy assessments as per standard care included:
a) Measures of passive range of motion (ROM) in upper limbs
(UL) and lower limbs (LL) performed uni- laterally and bi-
laterally at a minimum of weekly intervals. 
b) Recorded or self-reported measures of spasticity in terms
of mild, moderate or severe (UL, LL, truncal).
The presence of one or more of the following signs indi-
cated the possibility that NHO was present:
1) an objective decrease of more than 5 arc degrees (º) in pas-
sive ROM from previous assessment; 
2) an increase in severity of spasticity from the previous as-
sessment;
3) inflammatory signs at the hip/pelvis such as redness, heat,
and swelling;
4) abnormal joint “end feel” on passive ranging (flexion/ab-
duction hip).
Clinical suspicion of NHO i.e. the presence of one or more
of the above signs and symptoms was confirmed or excluded
by radiography using the technetium whole body bone scan11.
Audit protocol
We adopted the audit protocol originally developed by
Goldman (1980) and modified according to more recently pub-
lished literature6,10,13,15. The audit itself was conducted between
February and August 2013 and clinically relevant characteris-
tics, as previously identified from the literature, were manually
extracted and recorded in a Microsoft Excel spread sheet.
Where information was missing or sparse the treating physi-
cian or physiotherapist was consulted. The list of all variables
recorded is shown in Supplementary Table 1. Recorded data
were subsequently statistically analysed to identify TBI and
TSCI patients at high risk of developing NHO. A priori risk
factors in the development of NHO in TSCI and TBI respec-
tively, are as documented in Tables 1 and 2.
Statistical analysis
Univariate association of continuous and nominal covariates
with NHO was examined by Mann-Whitney U test and Fisher’s
exact test, respectively. Our binary outcome was the presence
of NHO in patients with TBI or TSCI. Logistic regression was
used to model the effects of multiple covariates on binary out-
come and results were presented as odds ratio (OR) with its
95% confidence interval (95% CI). Statistical significance was
defined at the conventional 5% level. All computations were
performed using the SPSS statistical package v.20.0.0.
Results
The OACIS tool identified 262 TBI patients, 151 TSCI patients,
and 11 patients with a combined head and spinal cord injury ad-
mitted to the Hampstead Rehabilitation Centre between January 1
2007 and December 31 2012. The latter 11 patients were consid-
ered to be confounders and were removed from further analyses.
NHO was diagnosed in 10 and 16 patients with TBI and TSCI, re-
spectively (Supplementary Table 1). Eighteen clinically relevant
characteristics were recorded and analysed for the association with
NHO in TBI and TSCI patients (Supplementary Table 1).
Mode of injury in patients with TBI and TSCI
The most common modes of injury, accounting for more
than 50% of all identified TBI and TSCI patients, were falls
(TBI=23.66%, TSCI=18.54%), driver or passenger motor ve-
hicle accidents (TBI=22.90%, TSCI=27.81%), and motorbike
accidents (TBI=17.89%, TSCI=18.54%), (Figure 1). TBI,
compared to TSCI, was significantly more associated with as-
saults (15.64% vs. 0.66%, P<0.001) and pedestrian accidents
(8.78% vs. 0.66%, P<0.001). On the other hand TSCI as com-
pared to TBI was significantly more associated with sporting
accidents (TSCI=11.92%, TBI=1.91%, P<0.001), industrial or
work related accidents (TSCI=5.96%, TBI=0.00%, P<0.001),
and accidents associated with flying activities (TSCI=2.65%,
TBI=0.00%, P=0.017) (Figure 1).
Diagnosis of NHO in patients with TBI and TSCI
NHO was diagnosed by radiography using the technetium
whole body bone scan11, when it became clinically significant.
All TBI and TSCI patients who developed clinically significant
NHO had decreased ROM at the affected joint by at least 5˚.
Sites of NHO in patients with TBI and TSCI
Both groups developed NHO most commonly in the hip
joint. The elbow was involved significantly more often in TBI
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patients than TSCI patients (Table 3). 
With regards to the sites of NHO, elbows were unilaterally
affected in TBI patients rather than TSCI patients (30% vs.
0%, P=0.046; Table 3). However, NHO developed unilaterally
more often in the hip area in TSCI patients than TBI patients
(63% vs. 40%), though the difference did not reach statistical
significance (P=0.301; Table 3).
Risk factors associated with NHO in patients with TBI and TSCI
We performed the analysis of clinically relevant variables in
TBI and TSCI patients to assess their association with NHO.
We found that the prevalence of NHO in TBI patients was about
one-third of that found in TSCI patients, 4% and 11%, respec-
tively (Table 4). The only variables that appeared to be com-
monly associated with NHO in both neurological conditions
Figure 1. Bar graph showing the numbers of patients with TBI and TSCI according to the mode of injury. (TBI= Traumatic Brain Injury; TSCI= Trau-
matic Spinal Cord Injury; MVA= motor vehicle accident; MBA= Motorbike accident; n= number of patients; *statistically significant difference).
Joint TBI-HO (n=10*) TSCI-HO (n=16*) P
Shoulder Unilateral 0 (0%) 0 (0%) -
Bilateral 0 (0%) 1 (6%) >0.999
Elbow Unilateral 3 (30%) 0 (0%) 0.046
Bilateral 0 (0%) 0 (0%) -
Hip Unilateral 4 (40%) 10 (63%) 0.301
Bilateral 0 (0%) 3 (19%) 0.215
Knee Unilateral 3 (30%) 1 (6%) 0.157
Bilateral 0 (0%) 1 (6%) >0.999
NHO= Neurogenic Heterotopic Ossification; TBI-HO= Traumatic Brain Injury with Heterotopic Ossification; TSCI-HO= Traumatic 
Spinal Cord Injury with Heterotopic Ossification; *n = number of patient with clinically significant NHO (some patients had more than
one site affected).
Table 3. Sites of NHO.
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Characteristic TBI TSCI
NHO No NHO P NHO No NHO P
N 10 (4%)* 252 (96%) - 16 (11%)* 135 (89%) -
Age (years) 39.6±15.5 39.9±16.2 0.852 31.4±10.9 38.1±17.5 0.288
Male 10 (100%) 216 (86%) 0.366 13 (81%) 115 (85%) 0.713
Female 0 (0%) 36 (14%) 0.366 3 (19%) 20 (15%) 0.713
ISNCSCI level Cervical - - - 11 (69%) 68 (50%) 0.177
Thoracic - - - 5 (31%) 49 (36%) 0.715
Lumbar - - - 0 (0%) 10 (7%) 0.314
Cauda Equina - - - 0 (0%) 8 (6%) 0.399
AIS score A - - - 8 (50%) 53 (39%) 0.422
B - - - 6 (38%) 16 (12%) 0.017
C - - - 1 (6%) 19 (14%) 0.430
D - - - 1 (6%) 39 (29%) 0.046
E - - - 0 (0%) 1 (1%) 0.894
Central cord lesion - - - 0 (0%) 5 (4%) 0.567
Hemi-section of cord - - - 0 (0%) 2 (1%) 0.799
Lowest Nil/not noted 2 (20%) 63 (25%) 0.773 - - -
GCS at time Mild 2 (20%) 59 (23%) 0.857 - - -
of injury Moderate 0 (0%) 44 (18%) 0.154 - - -
Severe 6 (60%) 86 (34%) 0.116 - - -
Length of PTA No 4 (40%) 121 (48%) 0.640 - - -
(days) Mild 0 (0%) 0 (0%) - - - -
Moderate 0 (0%) 3 (1%) 0.889 - - -
Severe 0 (0%) 14 (6%) 0.572 - - -
Very severe 6 (60%) 114 (45%) 0.382 - - -
Period of <1 0 (0%) 19 (7%) >0.999 - - -
Intubation 2-5 0 (0%) 17 (7%) >0.999 - - -
(days) 6-10 0 (0%) 11 (4%) >0.999 - - -
11-15 0 (0%) 4 (1%) >0.999 - - -
16-25 1 (10%) 9 (4%) 0.327 - - -
>25 3 (30%) 7 (3%) 0.004 - - -
Unknown 4 (40%) 57 (23%) 0.245 - - -
Not noted 2 (20%) 128 (51%) 0.103 - - -
Spasticity 5 (50%) 9 (4%) <0.001 10 (63%) 65 (48%) 0.303
Level of intoxication 0 (0%) 18 (7%) >0.999 - - -
Urinary tract infections 3 (30%) 23 (9%) 0.065 13 (81%) 78 (58%) 0.104
Albumin (g/L) 35.1±3.7 36.1±4.5 0.387 33.9±2.8 33.2±4.8 0.549
WCC (109/L) 8.0±3.4 7.8±2.8 0.556 7.9±2.7 8.1±2.8 0.823
DVT/PE 4 (40%) 16 (6%) 0.004 4 (25%) 8 (6%) 0.025
Pressure Ulcers Pre-pressure areas - - - 0 (0%) 2 (2%) >0.999
Heels/malleoli 1 (10%) 4 (2%) 0.178 0 (0%) 6 (4%) >0.999
Sacral area/buttocks 0 (0%) 3 (1%) >0.999 4 (25%) 13 (10%) 0.085
Ischial tuberosity - - - 1 (6%) 6 (4%) 0.551
Multiple pressure ulcers - - - 5 (31%) 9 (7%) 0.008
Miscellaneous (ear) 0 (0%) 1 (1%) >0.999 - - -
High risk but not noted 1 (10%) 3 (1%) 0.145 - - -
Nil noted 8 (80%) 241 (95%) 0.082 6 (38%) 99 (73%) 0.007
Pre-pressure areas - - - 0 (0%) 2 (2%) >0.999
Table 4. Univariate analysis of patients with and without NHO after traumatic brain and spinal cord injuries (continuous on the next page).
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Characteristic TBI TSCI
NHO No NHO P NHO No NHO P
Length of stay 143±117 54.7±16.2 <0.001 207±175 122±113 0.055
Smokers/ 1 (10%) 32 (13%) >0.999 5 (31%) 26 (19%) 0.324
non smokers
Associated Injuries Multiple injuries 6 (60%) 59 (23%) 0.017 2 (13%) 11 (8%) 0.631
Spinal dislocation - - - 13 (81%) 78 (58%) 0.104
Co-morbidities
Asthma 0 (0%) 5 (2%) >0.999 0 (0%) 9 (7%) 0.598
Cardiovascular disorders 0 (0%) 7 (3%) >0.999 0 0(%) 4 (3%) >0.999
Orthopaedic disorders 1 (10%) 5 (2%) 0.210 1 (6%) 14 (10%) >0.999
Systemic disorders 1 (10%) 10 (4%) 0.354 1 (6%) 7 (5%) >0.999
Chronic pain 0 (0%) 2 (1%) >0.999 0 (0%) 2 (1%) >0.999
Psychiatric disorders 2 (20%) 17 (7%) 0.158 0 (0%) 3 (2%) >0.999
Alcoholism 0 (0%) 20 (8%) >0.999 0 (0%) 3 (2%) >0.999
Miscellaneous co-morbidities 1 (10%) 8 (3%) 0.299 0 (0%) 14 (10%) 0.364
CCI 0.6±0.9 0.3±0.7 0.175 0.2±0.4 0.5±0.8 0.410
TBI – Traumatic brain injury TSCI – Traumatic spinal cord injury
NHO – Neurogenic heterotopic ossification ASIA – American Spinal Injuries Association
ISNCSCI – International Standard for Neurological Classification of Spinal Cord Injury
AIS – ASIA Impairment scale PTA – Post-traumatic amnesia
GCS – Glasgow coma scale PE – Pulmonary embolus
DVT – Deep vein thrombosis
CCI – Age-adjusted Charlson Comorbidity Index WCC – White Cell Count
Nominal variables are presented as numbers; continuous variables are presented as mean ± standard deviation. Continuous and nominal variables
were compared between subjects with and without NHO using Mann Whitney U test and Fisher’s exact test, respectively.
Reference: Charlson ME, Pompei P, Ales KA, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: 
Development and validation. Journal of Chronic Diseases. 1987;40(5):373-83.
Table 4. (continued from previous page).
Risk factor TBI TSCI
OR 95% CI P OR 95% CI P
Spasticity 27.75 6.40-120.27 <0.001 - - -
Period of intubation (>25 days) 18.73 3.64-96.24 <0.001 - - -
Urinary tract infections 6.74 1.55-29.27 0.011 - - -
Multiple injuries 5.70 1.54-21.07 0.009 - - -
Length of stay 1.00 1.00-1.01 0.120 - - -
Multiple pressure ulcers - - - 5.61 1.55-20.30 0.009
AIS score B - - - 3.59 1.09-11.79 0.035
AIS score D - - - 0.20 0.02-1.65 0.136
TBI - Traumatic brain injury TSCI – Traumatic spinal cord injury
DVT – Deep vein thrombosis AIS –ASIA Impairment scale
PE - Pulmonary embolus
OR, odds ratio; CI, 95% confidence intervals; P, P-value.
The association between individual risk factors and NHO was adjusted for age and gender.
Table 5. Multivariate association of risk factors with NHO in patients with traumatic brain and spinal cord injuries.
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were deep vein thrombosis and/or pulmonary emboli (DVT/PE).
The prevalence of DVT/PE in TBI patients with NHO was 40%
compared to 6% in TBI patients without NHO (P=0.004). The
prevalence of DVT/PE in TSCI patients with and without NHO
was 25% and 6%, respectively (P=0.025; Table 4). Certain vari-
ables appeared to be exclusively associated with NHO in TBI
or TSCI patients. In the TBI group of patients these include spas-
ticity, period of intubation, urinary tract infections, multiple in-
juries and the length of stay (Table 4). In the TSCI group,
patients with NHO, compared to patients without NHO, showed
a significantly higher prevalence of multiple pressure ulcers and
AIS B (ASIA Impairment Scale, Appendix 1) (Table 4). It
should be noted however, that TSCI patients (AIS D) with NHO
as compared to patients without NHO (i.e. sensory and motor
incomplete), showed significantly less prevalence of NHO
(Table 4). Adjusting for age and gender, DVT/PE remained a
common predictor of NHO in both TBI patients (OR=10.35,
95% CI=2.51-43.63, P=0.001) and TSCI patients (OR=5.57,
95% CI=1.41-21.98, P=0.014) using logistic regression analysis
(Table 5). Spasticity (OR=27.75, 95% CI=6.40-120.27,
P<0.001) followed by the period of intubation >25 days
(OR=18.73, 95% CI=3.64-96.24, P<0.001) urinary tract infec-
tion (OR=6.74, 95% CI=1.55-29.27, P=0.011) and multiple in-
juries (OR=5.70, 95% CI=1.54-21.07, P=0.009) were identified
as predictors of NHO in TBI patients using logistic regression
analysis (Table 5). Similarly, multiple pressure ulcers (OR=5.61,
95% CI=1.55-20.30, P=0.009) and AIS score B (OR=3.59, 95%
CI=1.09-11.79, P=0.035) were predictors of NHO in TSCI pa-
tients using logistic regression analysis (Table 5). 
Discussion
In the current study we screened a group of 413 patients
with traumatic brain and spinal cord injuries for the presence
of NHO. Our findings provide evidence that prevalence of
NHO in TBI patients is less than one-third of that found in
TSCI patients, in particular accounting for ~4% and 11%, re-
spectively. These findings are similar to older estimates of
NHO prevalence being about 3% and 4% in TBI and TSCI pa-
tients, respectively16,17. More recently published figures, how-
ever, are at least five-times higher in both neurological
conditions15. The prevalence of NHO varies widely among in-
stitutions, as some specialised units screen for NHO routinely
while others report only clinically significant NHO cases21.
This might contribute to our relatively conservative estimates
of NHO prevalence in TBI and TSCI patients as some of the
most prominent complications of NHO, such as joint ankylo-
sis, manifest themselves only in small number of patients22. 
The most notable finding from this study was that the risk
factors associated with NHO in TBI and TSCI patients were
almost completely distinct, suggesting that clinically signifi-
cant NHO following traumatic brain and spinal cord injuries
are clearly separate entities in terms of their associated risk
factors. In addition we found an increase in the number of deep
vein thromboses (DVT) prior to the diagnosis of NHO among
the TBI and TSCI patients who subsequently developed NHO.
DVT remained the only common risk factor for NHO in
these patients even after adjustment for other clinically relevant
variables such as age and gender. This is expected as both TBI
and TSCI patients often present with a number of additional
risk factors associated with DVT development, including major
surgery, fractures of the pelvis, hip, or long bones, and trauma,
all of which can stimulate the levels of thrombogenic factors,
such as factor III or thromboplastin, within the circulation23.
Current understanding of the NHO pathogenesis supports the
idea that multiple factors are crucial for its initiation and pro-
gression rather than a single risk factor such as DVT15. Indeed,
approximately half of our TBI and TSCI patients who devel-
oped NHO had no symptoms of DVT. In descending order, ac-
cording to the effect size, TBI patients with spasticity, period
of intubation greater than 25 days, urinary tract infections, and
multiple injuries had a higher risk of developing NHO. Most
of these risk factors have been previously reported to be asso-
ciated with NHO21; however, prolonged endotracheal intuba-
tion may represent a novel risk factor for NHO in TBI patients.
A similar but more invasive surgically based ventilation tech-
nique, a tracheostomy, was previously associated with in-
creased risk of NHO in TSCI but not TBI patients21. This was
not the case in our TSCI group, where patients with multiple
pressure ulcers, and AIS score B had the highest risk of devel-
oping NHO. One of the most important orthopaedic concerns
for NHO is its ability to impair the mobility of sufferers. In this
context, the functional significance of incomplete lesions as a
risk factor for NHO is arguable, since mobility is already se-
verely limited in this group of patients24.
There are many reasons why risk factors for NHO are dis-
tinct in TBI and TSCI patients. It is possible that the mode of
injury may contribute to the mechanisms of NHO formation,
as the causes of upper motor neurone lesions were considerably
different in TBI and TSCI patients. The prevalence of assaults
and pedestrian motor vehicle accidents was significantly higher
in traumatic brain injury cases, whereas sporting, flying, and
industrial accidents appeared to be significantly more prevalent
in patients with spinal cord injuries. These causes of TSCI fre-
quently lead to prolonged or chronic physical impairements as-
sociated with the pressure ulcers25, a recognized risk factor for
NHO in TSCI patients21. Pressure ulcers also had the highest
effect size in this study. On the other hand, assaults to the head
often result in an increase in muscle activity and spasticity26;
spasticity is a recognized risk factor for NHO in TBI patients21.
NHO is found predominantly in the larger joints such as
hips, knees, shoulders, and elbows3,11. In the current study we
found that NHO predominantly developed in the elbow of TBI
rather than TSCI patients. The exact mechanism for this find-
ing is not evident in the current study; however TBI patients
significantly differed from those with TSCI in terms of their
risk factors for NHO development, including the level of spas-
ticity. Thus it is reasonable to suggest that upper limb spastic-
ity, associated with mechanical stress to the musculotendinous
junction at the elbow joint, due to handling, might account for
the relatively higher number of TBI patients who developed
NHO around the elbow. This hypothesis is supported by pre-
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vious findings that micro trauma may induce ossification
through induction of local inflammatory responses or by re-
leasing osteoblast-stimulating factors27.
Finally, we also assessed some circulating inflammatory
markers such as serum albumin and white blood cell count in
TBI and TSCI patients. We found that patients with and with-
out NHO had similar levels of these blood-borne indicators of
systemic inflammation. This is in accord with previous find-
ings which provides evidence that the use of common antiin-
flammatory agents, such as indomethacin, ibuprofen and
aspirin, has only limited effectiveness in the pharmacological
management of NHO10. Thus some other clinical interventions
such as the extracorporeal shock wave therapy (ESWT) could
be investigated for their effectiveness in these patients28,29. 
The current study has several limitations; in order to mini-
mize some of the difficulties in identifying patients, the study
was conducted at specialised brain injury and spinal cord in-
jury units at one rehabilitation centre that implemented the
OACIS system. This tool allows for gathering relevant clinical
data and patients characteristics in a very uniform, precise
manner. As a result of this design, NHO was identified only
when it was a clinically significant condition, thus the number
of TBI and TSCI patients with NHO was relatively small
which may limit the statistical power, and the number of risk
factors identified in the study. This study, however, was a ret-
rospective audit, and the findings need to be confirmed in a
large prospective study. A further limitation was that the ma-
jority of available TBI and TSCI patients were male, limiting
the relevance of our findings to NHO in women. Finally, it
must be noted that the period of intubation for the TSCI pa-
tients was not available using the OACIS tool, and might be
useful information to have in future studies.
In conclusion, this study suggests that the risk factors asso-
ciated with NHO in TBI patients are distinct from those iden-
tified in TSCI patients. Our findings may have practical
implications in the clinical management of patients with NHO
following traumatic neurological injuries.
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Variable TBI TSCI
Patients (number) 262 151
NHO (number) 10 16
Combined (number) 11
Date of injury √ √ 
Age at time of injury √ √ 
Gender √ √ 
ISNCSCI X √ 
AIS X √ 
GCS √ X 
Length of time in PTA √ X 
Presence of NHO /number of joints affected √ √ 
Presence of DVT/PE √ √ 
Presence of UTI √ √ 
Presence/ number of PU’s √ √ 
Presence of spasticity √ √ 
Mechanical ventilation √ X 
Respiratory disorders √ √ 
Cardiovascular disorders √ √ 
Co - morbidities Orthopaedic disorders √ √ 
Chronic pain √ √ 
Psychiatric disorders √ √ 
EtOH abuse √ √ 
Length of stay in unit √ √ 
Mode of separation √ √ 
Nursing/Physiotherapy Management √ √ 
Blood Albumin (g/L) √ √ 
characteristics WCC (109/L) √ √ 
ISNCSI - International Standard Neurological Classification of Spinal
Cord Injury
DVT - Deep Vein Thrombosis
PE - Pulmonary Embolus
AIS - ASIA Impairment Scale
UTI - Urinary Tract Infection
GCS - Glasgow Coma Scale 
PU - Pressure Ulcer
PTA - Post Traumatic Amnesia
EtOH - Ethanol Abuse
NHO - Neurogenic Heterotopic Ossification
WCC - White Cell Count
Supplementary Table 1. Variables recorded.
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Appendix 1
Asia impairment scale
• ‘A’ being complete and having no sensory or motor function
preserved in the sacral segments of S4 to S5.
• ‘B’, sensory incomplete, is having sensation but not motor
function reserved below the neurological level and includes
the sacral segments S4-S5 (light touch, pinprick, at S4-S5:
or deep anal pressure (DAP)), and no motor function is pre-
served more than three levels below the motor level on either
side of the body. 
• ‘C’, motor incomplete, is motor function preserved below
the neurological level, and more than half of the key muscle
functions below the single neurological level of the injury
(NLI) have a muscle grade of less than 3 (grades 0-2). 
• ‘D’ is also motor incomplete and has motor function pre-
served below the neurological level, and at least half of the
key muscle functions below the NLI have a muscle grade
equal or greater than 3.
• ‘E’ is classified when sensation and motor function, as tested
with the ISNCSCI, are graded as normal in all segments and
the patient has had prior SCI deficits. (Someone without an
initial SCI does not receive an AIS grade)
Reference: Kirshblum SC, Waring W, Biering-Sorensen F,
Burns SP, Johansen M, Schmidt-Read M, Donovan W, Graves
D, Jha A, Jones L, Mulcahey MJ, Krassioukov A. Reference
for the 2011 revision of the International Standards for Neu-
rological Classification of Spinal Cord Injury. J Spinal Cord
Med 2011;34(6):547-54.
Appendix 2
Acute spinal cord injury - Frankel classification
grading system
Grade A Complete neurological injury - no motor or sen-
sory function clinically detected below the level of
the injury.
Grade B Preserved sensation only - no motor function clin-
ically detected below the level of the injury; sen-
sory function remains below the level of the injury
but may include only partial function (sacral spar-
ing qualifies as preserved sensation).
Grade C Preserved motor non-functional - some motor
function observed below the level of the injury, but
is of no practical use to the patient.
Grade D Preserved motor function - useful motor function
below the level of the injury; patient can move
lower limbs and walk with or without aid, but does
not have a normal gait or strength in all motor
groups.
Grade E Normal motor - no clinically detected abnormality
in motor or sensory function with normal sphincter
function; abnormal reflexes and subjective sensory
abnormalities may be present.
Reference: Donovan WH, Brown DJ, Ditunno JF Jr, Dollfus P,
Frankel HL. Neurological issues. Spinal Cord 1997;35(5):275-81.
